Do We Really Need New Trials on Fulvestrant in Prostate Cancer?

被引：2
作者：
Fechon, Aude [1 ]
Droz, Jean-Pierre [1 ]
机构：
[1] Univ Lyon 1, F-69008 Lyon, France
来源：
ONKOLOGIE | 2010年 / 33卷 / 1-2期
关键词：
ABIRATERONE ACETATE; PHASE-II; CLINICAL-TRIALS; WORKING GROUP; CASTRATION; RECOMMENDATIONS; ANTIANDROGEN; INHIBITION; CELLS; CYP17;
D O I：
10.1159/000271605
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：12 / 13
页数：2
相关论文
共 50 条
  • [1] Immunotherapy for metastatic prostate cancer: do we really need this?
    Heidenreich, A.
    UROLOGE, 2012, 51 (01): : 32 - 38
  • [2] Do we need randomised trials for rare cancers?
    Prasad, Vinay
    Oseran, Andrew
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (11) : 1355 - 1357
  • [3] Vitamin D and Lipids Do We Really Need More Studies?
    Jorde, Rolf
    Grimnes, Guri
    CIRCULATION, 2012, 126 (03) : 252 - 254
  • [4] Why do subjects on clinical trials discontinue therapy? Do we really know?
    Medeiros, Bruno C.
    Gale, Robert Peter
    LEUKEMIA RESEARCH, 2016, 51 : 19 - 21
  • [5] Do we need to reconsider how we design and conduct randomized controlled trials?
    Batra, Gorav
    Wallentin, Lars
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (04) : 374 - 376
  • [6] When do we need clinical endpoint adjudication in clinical trials?
    Held, Claes
    UPSALA JOURNAL OF MEDICAL SCIENCES, 2019, 124 (01) : 42 - 45
  • [7] Do We Need Independent Data Monitoring Boards and Adaptive Designs for Diagnostic Outcome Trials?
    Fraser, Alan G.
    Zaidi, Abbas
    JACC-CARDIOVASCULAR IMAGING, 2018, 11 (08) : 1119 - 1121
  • [8] Spontaneous acute superficial vein thrombosis of the legs: do we really need to treat?
    Decousus, H.
    Bertoletti, L.
    Frappe, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : S230 - S237
  • [9] Outcome assessment for clinical trials: How many adjudicators do we need?
    Walter, SD
    Cook, DJ
    Guyatt, GH
    King, D
    Troyan, S
    CONTROLLED CLINICAL TRIALS, 1997, 18 (01): : 27 - 42
  • [10] MRI in prostate cancer diagnosis: do we need to add standard sampling? A review of the last 5 years
    Stabile, Armando
    Giganti, Francesco
    Emberton, Mark
    Moore, Caroline M.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (04) : 473 - 487
12345